CHARACTERIZATION OF VARIOUS VIRULENCE PROPERTIES OF DRUG-RESISTANT KLEBSIELLA ISOLATES: AN IN VITRO STUDY AMONG SUPERBUGSâ€
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i4.23965Keywords:
Klebsiella species, Capsule, Biofilm, Hemagglutination, Hypermucoviscosity, Siderophores, Multidrug resistanceAbstract
 Objective: The objective of this study was to evaluate the various virulence factors among all extended-spectrum beta-lactamase (ESBL)-producing Klebsiella isolates.
Methods: Klebsiella species (n=201) isolated from various non-repeated clinical samples from October 2016 to May 2017 were collected and identified by biochemical method and confirmed by BD Phoenix. Antibiotic susceptibility test was performed by Kirby-Bauer disc diffusion method, and ESBL detection was done by combined disc diffusion method. Capsule detection was done by nigrosin dye staining, hypermucoviscosity was done by string test, biofilm was performed by microtiter plate assay, and hemagglutination was performed with human erythrocytes treated with tannic acid.
Results: Among 201 ESBL-producing Klebsiella isolates, 63.2 % were multidrug resistance and 24.4% were extensively drug-resistant. Among these isolates, Klebsiella infection is more in older patients. All isolates were (100%) positive for capsule and siderophores production. Of all 201 isolates, 14 (7%) were strong, 61 (30.3%) were moderate, and 104 (51.8%) were weak biofilm producers. Among these isolates, 36 (17.9%) were type 1 fimbriae, 140 (69.7%) were type 3 fimbriae, and only 17 (8.5%) were positive for hypermucoviscosity.
Conclusion: Several virulence factors were studied, in which biofilm with fimbriae is the main cause for the resistance of antibiotics. Bacterial resistance profile found to be high with ESBL production and multiple drug resistance in the majority of the Klebsiella isolates, which is a result of improper antibiogram schedule and their virulence property.
Downloads
References
Mulla S, Kumar A, Rajdev S. Comparison of MIC with MBEC assay for in vitro antimicrobial susceptibility testing in biofilm forming clinical bacterial isolates. Adv Microbiol 2016;6:73-8.
Jonnalagadda S, Deshabathini UK. Anti-Quorum sensing potential of Moringa oleifera seed extract. Int J Pharm Pharm Sci 2016;8:76-82.
Schroll C, Barken KB, Krogfelt KA, Struve C. Role of Type 1 and Type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol 2010;10:179.
Kumar E, Usha K, Ramana BV, Chaudhury A, Sai Gopal DV. Plasmid profile and curing, biofilm detection among ESBL producing isolates of Acinetobacter species. Int J Pharm Pharm Sci 2016;8:39-42.
Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumonia A new and dangerous breed. Virulence 2013;4:107-18.
Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 2014;3:743-58.
Podschun R, Ullmann U. Klebsiella spp. As nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603.
Collee JG. Mackie and McCartney Practical Medical Microbiology. 14th ed. London: Churchill Livingstone. 1996; 17-30.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Six Informational Supplement. Vol. 30, M100-S26. Wayne, Pa, USA: CLSI; 2016.
Aljanaby AA, Alhasani AH. Virulence factors and antibiotic susceptibility patterns of multidrug resistance Klebsiella pneumoniae isolated from different clinical infections. Afr J Microbiol Res 2016;10:829-43.
O’Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS 365 proceeds via multiple convergent signaling pathways, A genetic analysis. Mol Microbiol 1998;28:449-61.
Duguid JP. Firnbriae and adhesive properties in Klebsiella strains. J Gen Microbiol 1959;21:271-86.
Schwyn B, Neilands JB. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987;160:47-56.
Nakkash AF, Al-Husseiny KR. Study some virulence factors of Klebsiella pneumoniae isolated from clinical sources. J Thi Qar Univ 2008;3:45-50.
Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, et al. Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome. BMC Infect Dis 2016;16:680.
Tarkkanen AM, Allen BL, Williams PH, Kauppi M, Haahtela K, Siitonen A, et al. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella Strains associated with human urinary tract infection. Infect Immun 1992;60:1187-92.
Chaudhary NK, Murthy SM. Urinary tract infection: Etiology and antimicrobial resistance with reference to adhesive organelles. J Drug Deliv Ther 2013;3:93-8.
Podschun R, Fischer A, Ullman U. Expression of putative virulence factors by clinical isolates of Klebsiella planticola. J Med Microbiol 2000;49:115-9.
Pramodhini S, Niveditha S, Umadevi S, Kumar S, Stephen S. Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterized patients in Pondicherry. Aust Med J 2012;5:344-8.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
